CN Patent
CN115380024B — 二氮杂螺吡喃化合物的晶型
Assigned to Medshine Discovery Inc · Expires 2024-03-15 · 2y expired
What this patent protects
一类二氮杂螺吡喃化合物的盐型、晶型(I)及其制备方法,还包括所述盐型和晶型在制备治疗相关疾病药物中的应用。
USPTO Abstract
一类二氮杂螺吡喃化合物的盐型、晶型(I)及其制备方法,还包括所述盐型和晶型在制备治疗相关疾病药物中的应用。
Drugs covered by this patent
- Talzenna (Talazoparib Tosylate) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.